These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9341604)

  • 1. Premature progesterone elevation spares blastulation but not pregnancy rates in in vitro fertilization with coculture.
    Fanchin R; Hourvitz A; Olivennes F; Taieb J; Hazout A; Frydman R
    Fertil Steril; 1997 Oct; 68(4):648-52. PubMed ID: 9341604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Premature progesterone elevation does not alter oocyte quality in in vitro fertilization.
    Fanchin R; Righini C; Olivennes F; de Ziegler D; Selva J; Frydman R
    Fertil Steril; 1996 Jun; 65(6):1178-83. PubMed ID: 8641494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consequences of premature progesterone elevation on the outcome of in vitro fertilization: insights into a controversy.
    Fanchin R; Righini C; Olivennes F; Ferreira AL; de Ziegler D; Frydman R
    Fertil Steril; 1997 Nov; 68(5):799-805. PubMed ID: 9389805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer.
    Fanchin R; de Ziegler D; Taieb J; Hazout A; Frydman R
    Fertil Steril; 1993 May; 59(5):1090-4. PubMed ID: 8486179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated progesterone in GnRH agonist down regulated in vitro fertilisation (IVFICSI) cycles reduces live birth rates but not embryo quality.
    Lahoud R; Kwik M; Ryan J; Al-Jefout M; Foley J; Illingworth P
    Arch Gynecol Obstet; 2012 Feb; 285(2):535-40. PubMed ID: 21853250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles.
    Xu B; Li Z; Zhang H; Jin L; Li Y; Ai J; Zhu G
    Fertil Steril; 2012 Jun; 97(6):1321-7.e1-4. PubMed ID: 22494924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progesterone elevation on the day of human chorionic gonadotropin administration adversely affects the outcome of IVF with transferred embryos at different developmental stages.
    Huang Y; Wang EY; Du QY; Xiong YJ; Guo XY; Yu YP; Sun YP
    Reprod Biol Endocrinol; 2015 Aug; 13():82. PubMed ID: 26238449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The slow growing embryo and premature progesterone elevation: compounding factors for embryo-endometrial asynchrony.
    Healy MW; Yamasaki M; Patounakis G; Richter KS; Devine K; DeCherney AH; Hill MJ
    Hum Reprod; 2017 Feb; 32(2):362-367. PubMed ID: 27986817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles.
    Kiliçdag EB; Haydardedeoglu B; Cok T; Hacivelioglu SO; Bagis T
    Arch Gynecol Obstet; 2010 Apr; 281(4):747-52. PubMed ID: 19862542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computerized assessment of endometrial echogenicity: clues to the endometrial effects of premature progesterone elevation.
    Fanchin R; Righini C; Olivennes F; Taieb J; de Ziegler D; Frydman R
    Fertil Steril; 1999 Jan; 71(1):174-81. PubMed ID: 9935138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.
    Engmann L; DiLuigi A; Schmidt D; Nulsen J; Maier D; Benadiva C
    Fertil Steril; 2008 Jan; 89(1):84-91. PubMed ID: 17462639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premature luteinization and in vitro fertilization outcome in gonadotropin/gonadotropin-releasing hormone antagonist cycles in women with polycystic ovary syndrome.
    Segal S; Glatstein I; McShane P; Hotamisligil S; Ezcurra D; Carson R
    Fertil Steril; 2009 May; 91(5):1755-9. PubMed ID: 18394616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of elevated serum progesterone during ovulation induction in in vitro fertilization-embryo transfer.
    Huang JC; Jackson KV; Hornstein MD; Ginsburg ES
    J Assist Reprod Genet; 1996 Sep; 13(8):617-24. PubMed ID: 8897120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of elevated peak serum progesterone levels.
    Orvieto R; Nahum R; Meltzer S; Liberty G; Anteby EY; Zohav E
    Gynecol Endocrinol; 2013 Sep; 29(9):843-5. PubMed ID: 23802563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the net effect of progesterone elevation on the day of hCG on live birth rates after IVF: a cohort analysis of 3296 IVF cycles.
    Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
    Hum Reprod; 2015 Mar; 30(3):684-91. PubMed ID: 25586787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Premature luteinization during controlled ovarian hyperstimulation for in vitro fertilization-embryo transfer has no impact on pregnancy outcome.
    Hofmann GE; Khoury J; Johnson CA; Thie J; Scott RT
    Fertil Steril; 1996 Dec; 66(6):980-6. PubMed ID: 8941065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled ovarian hyperstimulation does not adversely affect endometrial receptivity in in vitro fertilization cycles.
    Levi AJ; Drews MR; Bergh PA; Miller BT; Scott RT
    Fertil Steril; 2001 Oct; 76(4):670-4. PubMed ID: 11591397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does prolonged pituitary down-regulation with gonadotropin-releasing hormone agonist improve the live-birth rate in in vitro fertilization treatment?
    Ren J; Sha A; Han D; Li P; Geng J; Ma C
    Fertil Steril; 2014 Jul; 102(1):75-81. PubMed ID: 24746740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of an early (premature) rise of plasma progesterone in in vitro fertilization cycles induced by a "long protocol" of gonadotropin releasing hormone analogue and human menopausal gonadotropins.
    Shulman A; Ghetler Y; Beyth Y; Ben-Nun I
    J Assist Reprod Genet; 1996 Mar; 13(3):207-11. PubMed ID: 8852880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.